TOKYO -- Takeda Pharmaceutical plans to become the first Japanese drugmaker to market vaccines on a global scale, taking advantage of access to new sales channels gained from its acquisition of Irish peer Shire last year.
Pharmaceuticals
Takeda taps Shire's global network to sell prized dengue vaccine
Japanese drugmaker to utilize sales channels from massive acquisition
Takeda Pharmaceutical is developing the first vaccine for dengue fever that can be administered to children as young as four. (Photo courtesy of the company)
Read Next
Latest on Pharmaceuticals
